• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. BLAKE DRAIN UNKNOWN PRODUCT; CATHETER, IRRIGATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. BLAKE DRAIN UNKNOWN PRODUCT; CATHETER, IRRIGATION Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Wound Dehiscence (1154); Hematoma (1884); Inflammation (1932); Seroma (2069); Post Operative Wound Infection (2446)
Event Date 12/02/2020
Event Type  Injury  
Event Description
Title: comparison of peak plasmablade tm to conventional diathermy in abdominal-based free-flap breast reconstruction surgery¿a single-centre double-blinded randomised controlled trial.The aim of this study is to compare the ppb with the conventional diathermy for the raise of abdominal freeflaps in immediate and delayed breast reconstruction patients and compare outcomes, such as drain requirement, total drainage, inflammatory markers in drain fluid and complications, such as wound-healing problems and seroma formation.A single-centre, double-blinded, randomised controlled trial (rct) was conducted which included 108 abdominal based free-flap breast reconstruction patients who had their flap raise performed using either the ppb (n=56) or the conventional diathermy (n=52).At the end of the procedure, each patient received two abdominal 15 french blake drains(ethicon) connected to a low vacuum wound drainage system (85 kpa/neg, 100 mmhg).Drains were removed as per protocol when they produced =30 ml/24 h, with a maximum of 14 days.Reported complications included inflammation, abdominal drains, seroma with discomfort, abdominal wound infection, partial abdominal wound breakdown and abdominal hematoma.In conclusion the use of the ppb did not result in a significant reduction of drain requirement, total drain output or inflammatory cytokines but did reduce the size of seroma collections at the 2-week follow-up appointment.Therefore, the use of the ppb device could reduce early seroma formation after drain removal.
 
Manufacturer Narrative
(b)(4).Additional information has been requested however not received to date.If further details are received at a later date a supplemental medwatch will be sent.Were the cases discussed in this article previously reported to ethicon? if yes, please provide a complaint reference number.Does the surgeon believe that ethicon products involved: unknown blake drain caused and/or contributed to the post-operative complications (inflammation, abdominal drains, seroma with discomfort, abdominal wound infection, partial abdominal wound breakdown, abdominal hematoma) described in the article? does the surgeon believe there was any deficiency with the ethicon products: unknown blake drain used in these procedures? this report is related to a journal article; therefore, no product will be returned for analysis and the batch history records cannot be reviewed as the lot number has not been provided.The single complaint was reported with multiple events.There are no additional details regarding the additional events.Citation: journal of plastic, reconstructive & aesthetic surgery 74 (2021) 1731¿1742.Https://doi.Org/10.1016/j.Bjps.2020.12.007.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BLAKE DRAIN UNKNOWN PRODUCT
Type of Device
CATHETER, IRRIGATION
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
DEGANIA SILICON LTD.-INDIA
251, sector-6, imt manesar
gurgaon 12205 0
IN   122050
Manufacturer Contact
elba bello
1000 route 202
raritan, NJ 08869
MDR Report Key13172951
MDR Text Key288515503
Report Number2210968-2022-00104
Device Sequence Number1
Product Code GBX
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
CL I EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature
Reporter Occupation Other
Type of Report Initial
Report Date 01/05/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/05/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received12/09/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-